A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

The following is a summary of “Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis,” published in ...

Coronary artery lesions in patients with SARS-CoV-2 infection more likely to become high-risk plaques. HealthDay News — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is ...

The new virus, emerging in Wuhan, China, is called SARS-CoV-2 and is responsible for the disease known as COVID-19. SARS-CoV-2 spread quickly around the globe. Unlike SARS-CoV or MERS-CoV, SARS-CoV-2 ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID-19 who have mild symptoms and face a high risk of hospitalization. For ...

Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the company’s Aptima SARS-CoV-2 assay, which was first granted Emergency ...

In the graphics that follow, Scientific American presents detailed explanations, current as of mid-June, into how SARS-CoV-2 sneaks inside human cells, makes copies of itself and bursts out to ...

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

ACROBiosystems’ high-quality recombinant antigen proteins and kit products are considered to be vital in expediting the research and development of anti-SARS-CoV-2 vaccines and drugs.

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular ...